Mechanistically, PRDM15 regulates a transcriptional program that sustains the activity of the PI3K/AKT/mTOR pathway and glycolysis in B-cell lymphomas. This evidence concerns the gene PRDM15 and B-cell non-Hodgkin lymphoma.